• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Ginekol Pol . Evaluation of the presence of SARS-COV-2 in the vaginal fluid of reproductive-aged women

tetano

Editor, Senior Moderator
Ginekol Pol


. 2021 Mar 10.
doi: 10.5603/GP.a2021.0018. Online ahead of print.
Evaluation of the presence of SARS-COV-2 in the vaginal fluid of reproductive-aged women


Hilal Uslu Yuvac?[SUP] 1 [/SUP], Mehmet Musa Aslan[SUP] 2 [/SUP], Osman K?se[SUP] 1 [/SUP], Nermin Akdemir[SUP] 1 [/SUP], Hande Toptan[SUP] 3 [/SUP], Arif Serhan Cevrio?lu[SUP] 1 [/SUP], Mustafa Alt?ndi?[SUP] 3 [/SUP], Mehmet K?ro?lu[SUP] 3 [/SUP]



Affiliations

Abstract

Objectives: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is mainly transmitted through respiration and direct contact. The status of the infection in the female genital system is still unknown. The study aimed to evaluate whether SARS-CoV-2 is present in the vaginal fluid of women with COVID-19 infection in reproductive period.
Material and methods: Women who were between the ages of 18-50 years and clinically confirmed to have COVID-19 infection at our hospital between 20 April-31 May 2020 were included in the study. Women who were in their menstrual cycle during the study and who had a known cervical intraepithelial lesion and/or cancer, sexually transmitted disease and history and/or symptoms of vaginitis were excluded from the study. In patients in whom no pathology was detected during the examination, a sample was taken from the vaginal fluid for PCR by using Dacron tip swab. Analysis was performed with Genesig Real-Time PCR COVID-19 kit (Primer Design, England).
Results: Eighteen women who were in reproductive period and diagnosed with severe COVID-19 pneumonia were included in the study. The mean age of the patients was 38.16 ? 8.54. None of the patients were in their menopause period. The clinical symptoms of these women were similar to those of confirmed severe COVID-19 cases. SARS-CoV-2 was found to be negative in the samples taken from the vaginal fluid in all patients.
Conclusions: SARS-CoV-2 virus was not detected in the vaginal fluid of the patients who tested positive for COVID-19 in reproductive period.

Keywords: SARS-CoV-2; coronavirus; vaginal fluid.
 
Back
Top Bottom